Contact
Please use this form to send email to PR contact of this press release:
Study Presented at SABCS 2025 Demonstrates Identification of Low Risk Luminal Breast Cancer Patients Using MammaTyper®
TO:
Richard Hughes
Cerca Biotech GmbH